DGAP-News: BLACKHAWK CEO FREDERICK PELS AND MINDBIO THERAPEUTICS CO-FOUNDER JUSTIN HANKA WILL LEAD INVESTOR PRESENTATION AND Q&A SESSION WEDNESDAY, FEBRUARY 2nd AT 3PM PACIFIC STANDARD TIME
BLACKHAWK CEO FREDERICK PELS AND MINDBIO THERAPEUTICS CO-FOUNDER JUSTIN HANKA WILL LEAD INVESTOR PRESENTATION AND Q&A SESSION WEDNESDAY, FEBRUARY 2nd AT 3PM PACIFIC STANDARD TIME
- BLACKHAWK CEO FREDERICK PELS AND MINDBIO THERAPEUTICS CO-FOUNDER JUSTIN HANKA WILL LEAD INVESTOR PRESENTATION AND Q&A SESSION WEDNESDAY, FEBRUARY 2nd AT 3PM PACIFIC STANDARD TIME
The issuer is solely responsible for the content of this announcement. - Vancouver, British Columbia - February 1, 2022 - Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ) (the "Company" or "Blackhawk") is pleased to announce that its CEO Frederick Pels, along with MindBio Therapeutics co-founder, Justin Hanka, will conduct an investor presentation and question and answer session on Wednesday, Feburary 2nd at 3pm PST.
- Details of the investor presentation are as follows:
The presentation will be recorded and published on the MindBio https://mindbiotherapeutics.com and Blackhawk website on conclusion of the presentation. - Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies.